{"schema_version":"secwatch.filing_event.v1","accession":"0001516551-24-000091","form_type":"8-K","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.654047+00:00","generated_at":"2026-05-30T10:26:54.575342+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Skye Bioscience stockholders approve amended omnibus incentive plan, increasing share pool by 1.54M","bullets":["Stockholders voted 17.4M for, 6.2M against to approve the Amended and Restated Omnibus Incentive Plan.","Plan increases authorized shares by 1,535,655 and raises incentive stock option limit to 4,000,000.","Plan expiration extended to September 10, 2034; automatic share replenishment feature retained.","Approval became effective upon stockholder vote at Special Meeting on October 22, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001516551-24-000091","json":"https://secwatch.observer/filing/0001516551-24-000091.json","markdown":"https://secwatch.observer/filing/0001516551-24-000091.md","text":"https://secwatch.observer/filing/0001516551-24-000091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000151655124000091/0001516551-24-000091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000151655124000091/skye-20241022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:26:54.575342+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}